Last reviewed · How we verify

NCT05015465

AS-OCT Study of Cornea and Tear Film Parameters in Juvenile SLE Patients

Status unknown Last updated 20 August 2021
What this trial tests

trial testing Anterior Segment OCT in Juvenile Systemic Lupus Erythematosus in 140 participants. Status unknown.

Timeline
1 July 2020
Primary endpoint
1 October 2021
1 November 2021

Quick facts

Lead sponsorMinia University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment140
Start date1 July 2020
Primary completion1 October 2021
Estimated completion1 November 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 10 to 18, any sex, with Juvenile Systemic Lupus Erythematosus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of thie study to assess tear film parameters such as tear meniscus height (TMH), tear meniscus area (TMA), and tear meniscus depth (TMD). In addition, corneal pachymetry and epithelial thickness maps in juvenile SLE patients and compared to healthy subjects of similar age and gender.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Anterior Segment OCT

Trials testing the same drug.

Other recruiting trials for Juvenile Systemic Lupus Erythematosus

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05015465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing